The trademark application STAVANTA was filed by GlaxoSmithKline Biologicals S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 3, 2013, and it was registered by office on July 11, 2013 without any oppositions.
The application was filed in English (German was selected as the second language).
The renewal of the trademark was recorded by the office on December 2, 2022.
A transfer of the trademark registration was recorded on April 21, 2015. Appointment and Replacement of representative of the trademark registration was recorded on July 16, 2015. Appointment and Replacement of representative of the trademark registration was recorded on May 26, 2016. Deletion of the representative of the trademark registration was recorded on January 7, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 23, 2021.